133 related articles for article (PubMed ID: 10596904)
21. Structural requirements for inhibition of the neuronal nitric oxide synthase (NOS-I): 3D-QSAR analysis of 4-oxo- and 4-amino-pteridine-based inhibitors.
Matter H; Kotsonis P; Klingler O; Strobel H; Fröhlich LG; Frey A; Pfleiderer W; Schmidt HH
J Med Chem; 2002 Jul; 45(14):2923-41. PubMed ID: 12086480
[TBL] [Abstract][Full Text] [Related]
22. Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion.
Kozlov AV; Sobhian B; Duvigneau JC; Costantino G; Gemeiner M; Nohl H; Redl H; Bahrami S
J Lab Clin Med; 2002 Nov; 140(5):303-11. PubMed ID: 12434131
[TBL] [Abstract][Full Text] [Related]
23. Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes.
Zaman G; Pitsillides AA; Rawlinson SC; Suswillo RF; Mosley JR; Cheng MZ; Platts LA; Hukkanen M; Polak JM; Lanyon LE
J Bone Miner Res; 1999 Jul; 14(7):1123-31. PubMed ID: 10404012
[TBL] [Abstract][Full Text] [Related]
24. Alteration of the heme prosthetic group of neuronal nitric-oxide synthase during inactivation by N(G)-amino-L-arginine in vitro and in vivo.
Vuletich JL; Lowe ER; Jianmongkol S; Kamada Y; Kent UM; Bender AT; Demady DR; Hollenberg PF; Osawa Y
Mol Pharmacol; 2002 Jul; 62(1):110-8. PubMed ID: 12065761
[TBL] [Abstract][Full Text] [Related]
25. Secretagogue-stimulated pancreatic secretion is differentially regulated by constitutive NOS isoforms in mice.
DiMagno MJ; Hao Y; Tsunoda Y; Williams JA; Owyang C
Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G428-36. PubMed ID: 14551061
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
Joly GA; Narayanan K; Griffith OW; Kilbourn RG
Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.
Ichimori K; Stuehr DJ; Atkinson RN; King SB
J Med Chem; 1999 May; 42(10):1842-8. PubMed ID: 10346937
[TBL] [Abstract][Full Text] [Related]
28. [Physiological and physiopathological aspects of nitric acid in mammalian tissues].
Molero-Leal M
Invest Clin; 1998 Jun; 39(2):125-54. PubMed ID: 9707923
[TBL] [Abstract][Full Text] [Related]
29. Role of nitric oxide synthase isozymes in endotoxin-induced uveitis.
Mandai M; Mittag TW; Kogishi J; Iwaki M; Hangai M; Yoshimura N
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):826-32. PubMed ID: 8603867
[TBL] [Abstract][Full Text] [Related]
30. Inhibitors of human nitric oxide synthase isoforms with the carbamidine moiety as a common structural element.
Moore WM; Webber RK; Fok KF; Jerome GM; Kornmeier CM; Tjoeng FS; Currie MG
Bioorg Med Chem; 1996 Sep; 4(9):1559-64. PubMed ID: 8894112
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
[TBL] [Abstract][Full Text] [Related]
32. Fire ant venom alkaloid, isosolenopsin A, a potent and selective inhibitor of neuronal nitric oxide synthase.
Yi GB; McClendon D; Desaiah D; Goddard J; Lister A; Moffitt J; Meer RK; deShazo R; Lee KS; Rockhold RW
Int J Toxicol; 2003; 22(2):81-6. PubMed ID: 12745988
[TBL] [Abstract][Full Text] [Related]
33. Substrate binding and calmodulin binding to endothelial nitric oxide synthase coregulate its enzymatic activity.
Presta A; Liu J; Sessa WC; Stuehr DJ
Nitric Oxide; 1997 Feb; 1(1):74-87. PubMed ID: 9701047
[TBL] [Abstract][Full Text] [Related]
34. Transient changes in the synthesis of nitric oxide result in long-term as well as short-term changes in acetic acid-induced writhing in mice.
Larson AA; Kovacs KJ; Cooper JC; Kitto KF
Pain; 2000 May; 86(1-2):103-11. PubMed ID: 10779667
[TBL] [Abstract][Full Text] [Related]
35. KLYP956 is a non-imidazole-based orally active inhibitor of nitric-oxide synthase dimerization.
Symons KT; Massari ME; Nguyen PM; Lee TT; Roppe J; Bonnefous C; Payne JE; Smith ND; Noble SA; Sablad M; Rozenkrants N; Zhang Y; Rao TS; Shiau AK; Hassig CA
Mol Pharmacol; 2009 Jul; 76(1):153-62. PubMed ID: 19364813
[TBL] [Abstract][Full Text] [Related]
36. An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality.
Bianchi M; Ulrich P; Bloom O; Meistrell M; Zimmerman GA; Schmidtmayerova H; Bukrinsky M; Donnelley T; Bucala R; Sherry B
Mol Med; 1995 Mar; 1(3):254-66. PubMed ID: 8529104
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
38. Design of isoform-selective inhibitors of nitric oxide synthase.
Babu BR; Griffith OW
Curr Opin Chem Biol; 1998 Aug; 2(4):491-500. PubMed ID: 9736922
[TBL] [Abstract][Full Text] [Related]
39. Proteolytic degradation of nitric oxide synthase: effect of inhibitors and role of hsp90-based chaperones.
Osawa Y; Lowe ER; Everett AC; Dunbar AY; Billecke SS
J Pharmacol Exp Ther; 2003 Feb; 304(2):493-7. PubMed ID: 12538799
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine.
Bryk R; Wolff DJ
Biochemistry; 1998 Apr; 37(14):4844-52. PubMed ID: 9538001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
